Table 1 Patient characteristics
Clinical data | Non-MAFLD group (n = 105) | MAFLD group (n = 114) | P |
|---|---|---|---|
Age, years | 72.0 (69.0, 75.0) | 71.0 (68.0, 74.0) | 0.045 |
Sex | 0.699 | ||
Male | 46 (43.8%) | 47 (41.23%) | |
Female | 59 (56.2%) | 67 (58.77%) | |
BMI, kg/cm2 | 23.8 (21.5, 26.0) | 26.1 (24.2, 27.8) | < 0.001 |
Time from T2DM diagnosis, years | 14.0 (9.5, 20.0) | 10.0 (5.0, 15.0) | < 0.001 |
WHR | 0.90 (0.89, 0.96) | 0.92 (0.90, 1.00) | 0.018 |
Drinking history | 31 (29.5%) | 32 (28.1%) | 0.812 |
Diabetes history | 15 (14.3%) | 16 (14.0%) | 0.958 |
SBP (mmHg) | 130 (120, 142.5) | 130 (120, 140) | 0.615 |
DBP (mmHg) | 80 (70, 80) | 80 (70, 80) | 0.252 |
TC (mM) | 4.72 ± 1.01 | 4.60 ± 1.04 | 0.412 |
TG (mM) | 1.26 (0.92, 1.64) | 1.57 (1.21, 2.22) | < 0.001 |
HDL-C (mM) | 1.04 (0.89, 1.35) | 0.97 (0.82, 1.09) | 0.002 |
LDL-C (mM) | 2.85 ± 0.86 | 2.81 ± 0.95 | 0.733 |
ALT (IU/L) | 14.00 (10.00, 19.50) | 17.00 (13.00, 27.25) | 0.001 |
AST (IU/L) | 17.00 (13.50, 21.00) | 18.00 (14.00, 24.00) | 0.223 |
GGT (IU/L) | 18.00 (14.00, 25.50) | 24.00 (18.00, 34.25) | < 0.001 |
Scr (µmol/L) | 61.00 (53.50, 73.50) | 60.00 (51.75, 71.00) | 0.406 |
Asprosin (pg/ml) | 255.24 ± 82.52 | 291.71 ± 73.69 | 0.001 |
eGFR (mL/min/1.73 m2) | 128.78 (106.66, 154.52) | 131.28 (114.72, 158.91) | 0.612 |
HbA1C (%) | 8.50 (7.15, 10.55) | 8.95 (7.78, 10.4) | 0.233 |
FPG (mM) | 7.65 (5.98, 9.77) | 7.41 (6.50, 9.86) | 0.903 |
2hPG (mM) | 12.78 ± 4.59 | 13.20 ± 3.79 | 0.463 |
FINS (mIU/L) | 2.84 (2.00, 4.83) | 4.96 (3.43, 7.24) | < 0.001 |
HOMA-IR | 1.07 (0.6, 1.69) | 1.71 (1.29, 2.45) | < 0.001 |
FC-P (nM) | 1.81 (1.17, 2.43) | 1.94 (1.12, 2.48) | 0.614 |